Skip to content
OpenCapital
Get started

Regeneron Pharmaceuticals REGN SG&A

SG&A at other companies

Merck & Co. logo
Merck & Co.MRK
$2.7B+5.8%
Amgen logo
AmgenAMGN
$1.6B-5.0%
Glaukos logo
GlaukosGKOS
$92.94M+31.5%
Precigen logo
PrecigenPGEN
$21.05M+70.3%

Other financials

Income statement

See full
Revenue$3.6B+19.0%
Operating income$642.9M+8.7%
Net income$727.2M-10.1%
EPS (diluted)$6.75-7.2%

Balance sheet

See full
Cash & equivalents$3.0B-4.0%
Total debt$2.7B+0.1%
Total equity$31.4B+6.9%
Total assets$40.9B+8.9%

Cash flow

See full
Operating cash flow$1.1B+3.2%
CapEx$230.6M+0.6%
Free cash flow$848.3M+4.0%

Valuation

See full
Market cap$65.01B+18.1%
Enterprise value$64.75B+18.5%
P/E14.7×+2.5×
P/S4.4×+0.5×

Profitability

See full
Gross margin93.9%—
Operating margin24.3%-2.9pp
Net margin29.6%-2.3pp
FCF margin27.6%+5.5pp

Returns & leverage

See full
Return on equity14.5%-1.4pp
Debt / equity0.1×0.0×
Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regeneron Pharmaceuticals's SG&A?
Regeneron Pharmaceuticals (REGN) reported SG&A of $647.7M in Q1 2026.
How has Regeneron Pharmaceuticals's SG&A changed year-over-year?
Regeneron Pharmaceuticals's SG&A increased by 2.3% year-over-year, from $633M to $647.7M.
What is the long-term trend for Regeneron Pharmaceuticals's SG&A?
Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's SG&A has grown at a 10.3% compound annual growth rate (CAGR), from $1.82B to $2.7B.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.